CN Patent

CN112312926A — Gip/glp1激动剂组合物

Assigned to Eli Lilly and Co · Expires 2021-02-02 · 5y expired

What this patent protects

提供了替尔泊肽组合物，其包含：选自NaCl和丙二醇的试剂；和磷酸氢二钠。

USPTO Abstract

提供了替尔泊肽组合物，其包含：选自NaCl和丙二醇的试剂；和磷酸氢二钠。

Drugs covered by this patent

Patent Metadata

Patent number
CN112312926A
Jurisdiction
CN
Classification
—
Expires
2021-02-02
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.